Nociceptinski receptor (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nociceptinski receptor" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

9nih.gov

4^th place

3^rd place

8doi.org

2^nd place

4archive.org

6^th place

5^th place

archive.org (Global: 6^th place; Serbo-Croatian: 5^th place)

Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC (March 1994). „ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization”. FEBS Lett. 341 (1): 33–8. DOI:10.1016/0014-5793(94)80235-1. PMID 8137918.
Henderson G, McKnight AT (August 1997). „The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ”. Trends Pharmacol. Sci. 18 (8): 293–300. DOI:10.1016/S0165-6147(97)90645-3. PMID 9277133.
Calo' G, Guerrini R, Rizzi A, Salvadori S, Regoli D (April 2000). „Pharmacology of nociceptin and its receptor: a novel therapeutic target”. Br. J. Pharmacol. 129 (7): 1261–83. DOI:10.1038/sj.bjp.0703219. PMC 1571975. PMID 10742280.
Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L (December 2009). „Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists”. J. Pharmacol. Exp. Ther. 331 (3): 946–53. DOI:10.1124/jpet.109.156711. PMC 2784721. PMID 19713488.

doi.org (Global: 2^nd place; Serbo-Croatian: 2^nd place)

dx.doi.org

Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC (March 1994). „ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization”. FEBS Lett. 341 (1): 33–8. DOI:10.1016/0014-5793(94)80235-1. PMID 8137918.
Henderson G, McKnight AT (August 1997). „The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ”. Trends Pharmacol. Sci. 18 (8): 293–300. DOI:10.1016/S0165-6147(97)90645-3. PMID 9277133.
Liu Z, Wang Y, Zhang J, Ding J, Guo L, Cui D, Fei J (March 2001). „Orphanin FQ: an endogenous antagonist of rat brain dopamine transporter”. Neuroreport 12 (4): 699–702. DOI:10.1097/00001756-200103260-00017. PMID 11277567.
Calo' G, Guerrini R, Rizzi A, Salvadori S, Regoli D (April 2000). „Pharmacology of nociceptin and its receptor: a novel therapeutic target”. Br. J. Pharmacol. 129 (7): 1261–83. DOI:10.1038/sj.bjp.0703219. PMC 1571975. PMID 10742280.
Mørk H, Hommel K, Uddman R, Edvinsson L, Jensen R (September 2002). „Does nociceptin play a role in pain disorders in man?”. Peptides 23 (9): 1581–7. DOI:10.1016/S0196-9781(02)00101-8. PMID 12217418.
Scoto GM, Aricò G, Ronsisvalle S, Parenti C (July 2007). „Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia”. Peptides 28 (7): 1441–6. DOI:10.1016/j.peptides.2007.05.013. PMID 17628212.
Redrobe JP, Calo' G, Regoli D, Quirion R (February 2002). „Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test”. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2): 164–7. DOI:10.1007/s00210-001-0511-0. PMID 11819035.
Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L (December 2009). „Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists”. J. Pharmacol. Exp. Ther. 331 (3): 946–53. DOI:10.1124/jpet.109.156711. PMC 2784721. PMID 19713488.

nih.gov (Global: 4^th place; Serbo-Croatian: 3^rd place)

ncbi.nlm.nih.gov

Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC (March 1994). „ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization”. FEBS Lett. 341 (1): 33–8. DOI:10.1016/0014-5793(94)80235-1. PMID 8137918.
Henderson G, McKnight AT (August 1997). „The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ”. Trends Pharmacol. Sci. 18 (8): 293–300. DOI:10.1016/S0165-6147(97)90645-3. PMID 9277133.
„Entrez Gene: OPRL1 opiate receptor-like 1”.
Liu Z, Wang Y, Zhang J, Ding J, Guo L, Cui D, Fei J (March 2001). „Orphanin FQ: an endogenous antagonist of rat brain dopamine transporter”. Neuroreport 12 (4): 699–702. DOI:10.1097/00001756-200103260-00017. PMID 11277567.
Calo' G, Guerrini R, Rizzi A, Salvadori S, Regoli D (April 2000). „Pharmacology of nociceptin and its receptor: a novel therapeutic target”. Br. J. Pharmacol. 129 (7): 1261–83. DOI:10.1038/sj.bjp.0703219. PMC 1571975. PMID 10742280.
Mørk H, Hommel K, Uddman R, Edvinsson L, Jensen R (September 2002). „Does nociceptin play a role in pain disorders in man?”. Peptides 23 (9): 1581–7. DOI:10.1016/S0196-9781(02)00101-8. PMID 12217418.
Scoto GM, Aricò G, Ronsisvalle S, Parenti C (July 2007). „Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia”. Peptides 28 (7): 1441–6. DOI:10.1016/j.peptides.2007.05.013. PMID 17628212.
Redrobe JP, Calo' G, Regoli D, Quirion R (February 2002). „Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test”. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2): 164–7. DOI:10.1007/s00210-001-0511-0. PMID 11819035.
Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L (December 2009). „Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists”. J. Pharmacol. Exp. Ther. 331 (3): 946–53. DOI:10.1124/jpet.109.156711. PMC 2784721. PMID 19713488.

Nociceptinski receptor (Serbo-Croatian Wikipedia)

archive.org (Global: 6th place; Serbo-Croatian: 5th place)

doi.org (Global: 2nd place; Serbo-Croatian: 2nd place)

dx.doi.org

nih.gov (Global: 4th place; Serbo-Croatian: 3rd place)

ncbi.nlm.nih.gov

archive.org (Global: 6^th place; Serbo-Croatian: 5^th place)

doi.org (Global: 2^nd place; Serbo-Croatian: 2^nd place)

nih.gov (Global: 4^th place; Serbo-Croatian: 3^rd place)